Skip to Main Content
S. Karger AG Open Menu
header search
Search
Advanced Search
Skip Nav Destination

Issues

Volume 102, Issue 2
February 2024
Oncology Cover Image for Volume 102, Issue 2
All Issues
ISSN 0030-2414
EISSN 1423-0232

Journal Name Change

Vol. 1-20 (1948-1966) were published under the journal's former title Oncologia.

Oncology 2024, Vol. 102, No. 2

Clinical Study

18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance Imaging-Defined Extramural Venous Invasion Predicts Distant Metastasis and Reflects Strong Tumor Invasiveness in Rectal Cancer
Subject Area: Oncology
Takayuki Matsunaka; Takanori Goi; Hidetaka Kurebayashi; Mitsuhiro Morikawa; Hidehiko Okazawa; Tetsuya Tsujikawa
Oncology (2024) 102 (2): 99–106. https://doi.org/10.1159/000533422
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Survival Outcome in Early-Onset Metastatic Colorectal Cancer: A Multicenter-Matched Pair Analysis
Subject Area: Oncology
Bernhard Doleschal; Dora Niedersüß-Beke; Patrick Kirchweger; Andreas Petzer; Josef Thaler; Holger Rumpold
Oncology (2024) 102 (2): 107–113. https://doi.org/10.1159/000533429
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Impact of Oophorectomy on Survival and Improving Nutritional Status in Ovarian Metastasis from Colorectal Adenocarcinoma
Subject Area: Oncology
Yusuke Miyagawa; Masato Kitazawa; Shigeo Tokumaru; Satoshi Nakamura; Makoto Koyama; Yuta Yamamoto; Satoru Miyazaki; Nao Hondo; Yuji Soejima
Oncology (2024) 102 (2): 114–121. https://doi.org/10.1159/000533599
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Clinicopathological Characteristics of Breast Cancer Patients with HER-2 Low Expression Receiving Neoadjuvant Therapy
Subject Area: Oncology
Shiyuan Zhang; Xiao Yu; Yuting Xiu; Kun Qiao; Cong Jiang; Yuanxi Huang
Oncology (2024) 102 (2): 122–130. https://doi.org/10.1159/000533787
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Objective Response and Progression-Free Survival Contribute to Prolong Overall Survival in Atezolizumab plus Bevacizumab Treatment for Unresectable Hepatocellular Carcinoma
Subject Area: Oncology
Kazuto Tajiri; Kenichiro Tsukada; Yoshiharu Tokimitsu; Yuchi Motofuji; Kengo Kawai; Nozomu Muraishi; Aiko Murayama; Yuka Hayashi; Yukihiro Shimizu; Ichiro Yasuda
Oncology (2024) 102 (2): 131–140. https://doi.org/10.1159/000533952
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Consumption of Sugar-Sweetened Soft Drinks and Risk of Gastrointestinal Cancer: A Systematic Review and Meta-Analysis of Observational Studies
Subject Area: Oncology
Alfred Jatho; Seung-Kwon Myung; Jeongseon Kim; Sung-Sik Han; Sun Young Kim; Woong Ju
Oncology (2024) 102 (2): 141–156. https://doi.org/10.1159/000531110
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Clinical Translational Research

Mismatch Repair Deficiency in Biliary Tract Cancer: Prognostic Implications and Correlation with Histology
Subject Area: Oncology
Caterina Vivaldi; Virginia Genovesi; Clara Ugolini; Laura Bernardini; Andrea Casadei-Gardini; Vincenzo Formica; Francesca Salani; Giulia Orsi; Valentina Massa; Andrea Cacciato-Insilla; Miriam Caccese; Silvia Cesario; Kalliopi Andrikou; Jessica Graziani; Daniela Campani; Enrico Vasile; Gabriella Fontanini; Lorenzo Fornaro; Gianluca Masi
Oncology (2024) 102 (2): 157–167. https://doi.org/10.1159/000533406
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window

Oncology and Informatics – Research Article

Pan-Cancer Analysis of the Prognostic and Immunological Role of SMG5: A Biomarker for Cancers
Subject Area: Oncology
Leteng Yang; Jie Wei; Xiaoya Ma; Rui Cheng; Huan Zhang; Tianbo Jin
Oncology (2024) 102 (2): 168–182. https://doi.org/10.1159/000533421
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Survival Benefit from Multimodal Treatment for Patients with Atypical Teratoid Rhabdoid Tumor in a Surveillance, Epidemiology, and End Results Database Analysis
Subject Area: Oncology
Abhishek S. Bhutada; Srijan Adhikari; Joshua A. Cuoco; Cara M. Rogers; Eric A. Marvin
Oncology (2024) 102 (2): 183–194. https://doi.org/10.1159/000533508
View articletitled, SCM.SharedControls.Infrastructure.TitleDisplayModel?.Text
Open the PDF for in another window
Modified albumin-bilirubin grade and alpha-fetoprotein score for predicting prognosis of hepatocellular carcinoma patients undergoing conventional transarterial chemoembolization
Efficacy of locoregional treatment for oligo-drug-resistant lesions during first-line atezolizumab plus bevacizumab therapy for unresectable hepatocellular carcinoma: a single-center retrospective study
The Know-how Post-transplant Skin cancer for Immunotherapy and target therapies
Erratum - Alternative Palbociclib Dosing Schedules for Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer
  • Online ISSN 1423-0232
  • Print ISSN 0030-2414
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal